E‐cigarette, or vaping, product use‐associated lung injury (EVALI) results from inhaling the aerosol of e‐cigarettes and has similar clinical features to coronavirus disease 2019 (COVID‐19). EVALI case counts since the… Click to show full abstract
E‐cigarette, or vaping, product use‐associated lung injury (EVALI) results from inhaling the aerosol of e‐cigarettes and has similar clinical features to coronavirus disease 2019 (COVID‐19). EVALI case counts since the declaration of the COVID‐19 pandemic is unknown.
               
Click one of the above tabs to view related content.